0 9

Cited 0 times in

Cited 0 times in

Post-transplant outcomes by bridging strategy: A nationwide multicenter study of heart transplant recipients in Korea

Authors
 Kim, Darae  ;  Lee, Kyu-Sun  ;  Cho, Yang Hyun  ;  Lee, Hae-Young  ;  Kim, Myoung Soo  ;  Kim, Hyungseop  ;  Choi, Dong-Ju  ;  Lee, Sang Eun  ;  Kang, Seok-Min  ;  Lee, Soo Yong  ;  Cho, Hyun-Jai  ;  Choi, Jin-Oh 
Citation
 JOURNAL OF HEART AND LUNG TRANSPLANTATION, Vol.45(2) : 227-235, 2026-02 
Article Number
 PMID 9102703 
Journal Title
JOURNAL OF HEART AND LUNG TRANSPLANTATION
ISSN
 1053-2498 
Issue Date
2026-02
MeSH
Adult ; Extracorporeal Membrane Oxygenation* / methods ; Female ; Follow-Up Studies ; Heart Failure* / mortality ; Heart Failure* / surgery ; Heart Transplantation* ; Heart-Assist Devices* ; Hospital Mortality / trends ; Humans ; Male ; Middle Aged ; Registries* ; Republic of Korea / epidemiology ; Retrospective Studies ; Survival Rate / trends ; Transplant Recipients* ; Treatment Outcome
Keywords
Heart transplantation ; Extracorporeal membrane oxygenation ; Left ventricular assist device ; Mechanical circulatory support ; Survival
Abstract
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is prioritized in Korea's heart transplant (HTx) allocation system to reduce waitlist mortality, but post-transplant outcomes remain a concern. We compared post-transplant outcomes among HTx recipients bridged with ECMO, left ventricular assist device (LVAD), or without mechanical circulatory support (non-MCS). METHODS: We retrospectively analyzed 1021 adult HTx recipients enrolled in the Korean Organ Transplant Registry (2014-2023). Patients were categorized according to bridging strategy at transplantation (ECMO n = 357, LVAD n = 137, non-MCS n = 527). Outcomes included primary graft fection requiring hospitalization, and post-transplant mortality. RESULTS: ECMO bridging was associated with significantly higher risks of severe PGD (adjusted HR 3.68 vs non-MCS; 2.23 vs LVAD). In-hospital mortality was highest in ECMO recipients (17.9%) compared with LVAD-bridged (4.4%) and non-MCS recipients (4.4%) (P < 0.001). Kaplan-Meier analysis demonstrated significantly lower survival in the ECMO group at 90 days (83.2% vs 94.8% vs 95.0%) and 1 year (77.5% vs 89.0% vs 92.5%) (log-rankp < 0.0001). However, in 6-month landmark analyses, survival was similar across groups. Among ECMO recipients, those who died within 6 months had a markedly higher prevalence of pre-transplant dialysis (66.7% vs 34.7%, p < 0.001). The incidence of treated rejection and CAV did not differ significantly among the three groups. CONCLUSIONS: Direct ECMO bridging is associated with worse early post-transplant outcomes, primarily driven by severe PGD and early mortality, underscoring the need for careful candidate selection. LVAD bridging provided outcomes comparable to non-MCS and may offer a bridge-to-candidacy strategy for selected ECMO patients. J Heart Lung Transplant 2026;45:227-235 (c) 2025 International Society for Heart and Lung Transplantation. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
DOI
10.1016/j.healun.2025.09.023
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kang, Seok Min(강석민) ORCID logo https://orcid.org/0000-0001-9856-9227
Kim, Myoung Soo(김명수) ORCID logo https://orcid.org/0000-0002-8975-8381
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/211197
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links